Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
3,586,091
-
Share change
-
+915,256
-
Total reported value
-
$5,871,000
-
Put/Call ratio
-
8.9%
-
Price per share
-
$1.64
-
Number of holders
-
49
-
Value change
-
+$1,284,078
-
Number of buys
-
22
-
Number of sells
-
15
Institutional Holders of GALECTIN THERAPEUTICS INC - COM NEW (GALT) as of Q4 2015
As of 31 Dec 2015,
GALECTIN THERAPEUTICS INC - COM NEW (GALT) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,586,091 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, D.A. DAVIDSON & CO., AMERICAN INTERNATIONAL GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Neuberger Berman Group LLC, US BANCORP \DE\, Blue Clay Capital Management, LLC, BlackRock Fund Advisors, and CREDIT SUISSE AG/.
This page lists
49
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.